Skip to content

Clinical trials

Phase 4 Anxiety Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 4 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20071
20091
20102
20131
20151
20181
20191
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University2
Sunnybrook Health Sciences Centre2
Acadia University1
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal1
Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada1
Dr Alexander McIntyre Inc.1
Eli Lilly and Company1
Field Trip Health1
Hamilton Health Sciences Corporation1
Queen's University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders12
Attention Deficit Disorder with Hyperactivity3
Generalized Anxiety Disorder3
Agoraphobia2
Major Depressive Disorder2
Obsessive-Compulsive Disorder2
Panic Disorder2
Phobia, Social2
Agnosia1
Depressive Disorder1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.